electroCore (ECOR) Completes Acquisition of NeuroMetrix
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
May 2, 2025 8:00 AM EDTROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR, electroCore, or the Company) (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today the completion of the merger (the Merger) with NeuroMetrix, Inc. (NeuroMetrix or NURO) (Nasdaq: NURO), positioning itself as a diversified leader in non-invasive health and wellness solutions.
The acquisition of NeuroMetrixs Quell® Fibromyalgia Solution expands electroCores portfolio of non-invasive bioelectronic therapies, strengthens its commercial reach particularly within the VA Hospital System and is expected to meaningfully increase its addressable market for the treatment of chronic pain and wellness conditions.
Dan Goldberger, CEO... More
